11/23/2022
Paul Poommipanit, MD, FACC, FSCAI; Rhian E. Davies, DO, MD, MS, FACC, FSCAI; Judit Karacsonyi, MD, PhD; Stéphane Rinfret, MD, SM; Bavana V. Rangan, BDS, MPH, MD; Raj Chandwaney, MD; Nidal Abi Rafeh, MD; M. Nicholas Burke, MD; Abdul M. Sheikh, MD; Michael S. Megaly, MD, MS; Jaikirshan J. Khatri, MD; Luiz Fernando Ybarra, MD, PhD, MBA; Ahmed M. ElGuindy, MD, MSc, FRCP; Khaldoon Alaswad, MD; Basem Elbarouni, MD; Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI; Omer Goktekin, MD; Yader Sandoval, MD; Farouc A. Jaffer, MD, PhD; Catalin Toma, MD; Bahadir Simsek, MD; Spyridon Kostantinis, MD; Olga C. Mastrodemos, BA; Salman S. Allana, MD
Whether saphenous vein grafts (SVGs) should be occluded after successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) of the corresponding native vessel remains controversial.
Whether saphenous vein grafts (SVGs) should be occluded after successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) of the corresponding native vessel remains controversial.
Whether saphenous vein grafts...